Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

Rhea-AI Summary

Harvard Bioscience (HBIO) has announced its participation in the upcoming Sidoti Micro Cap Virtual Conference on January 22nd, 2025. The company's Chairman and CEO Jim Green, along with CFO Jennifer Cote, will deliver a presentation at 10:00 am ET.

The presentation will be accessible through a live webcast via the investor relations section of Harvard Bioscience's website. Interested parties can view the presentation replay after its conclusion. One-on-one meetings can be arranged through the conference organizers.

HOLLISTON, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Sidoti Micro Cap Virtual Conference on January 22^nd, 2025, with a presentation time of 10:00 am ET.

The presentation will be webcast live and can be accessed through the investor relations section of the Harvard Bioscience website: https://investor.harvardbioscience.com/events-and-presentations. A replay will be available on the company’s website shortly after the presentation has concluded.

To schedule a one-on-one meeting, please contact the conference organizers directly. 

About Harvard Bioscience, Inc. 
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. For more information, please visit our website at www.harvardbioscience.com 

Company Contact: 
Harvard Bioscience 
Jennifer Cote, Chief Financial Officer 
(508) 893-3120 

Investor Contacts: 
Three Part Advisors 
Sandy Martin / Erol Girgin
HBIO@threepa.com 
(214) 616-2207 

FAQ

When is Harvard Bioscience (HBIO) presenting at the Sidoti Micro Cap Conference 2025?

Harvard Bioscience (HBIO) is scheduled to present at the Sidoti Micro Cap Virtual Conference on January 22nd, 2025, at 10:00 am ET.

How can investors access HBIO's Sidoti Conference presentation?

Investors can access the live webcast through Harvard Bioscience's investor relations website at https://investor.harvardbioscience.com/events-and-presentations.

Will there be a replay available of HBIO's Sidoti Conference presentation?

Yes, a replay of the presentation will be available on Harvard Bioscience's website shortly after the presentation concludes.

Who will represent HBIO at the Sidoti Micro Cap Conference 2025?

Chairman and CEO Jim Green and CFO Jennifer Cote will represent Harvard Bioscience at the conference.

How can investors schedule one-on-one meetings with HBIO management at the Sidoti Conference?

Investors interested in one-on-one meetings should contact the Sidoti Conference organizers directly to schedule appointments.